COST-EFFECTIVENESS OF GLYCOPYRRONIUM / INDACATEROL COMBINATION VS. SALMETEROL/FLUTICASONE (FIXED DOSE COMBINATION - CDF) IN THE MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (EPOC) IN COLOMBIA (SOUTH AMERICA)

被引：0

作者：

Karpf, E. ^{[1
]}

Londono, D. ^{[2
]}

Olaya, A. ^{[1
]}

机构：

[1] Novartis Colombia, Bogota, DC, Colombia

[2] Fdn Santa Fe Bogota, Salud Publ, Bogota, DC, Colombia

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 07期

关键词：

D O I：

10.1016/j.jval.2015.09.372

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRS10

引用

页码：A840 / A840

页数：1

共 50 条

[41] Cost-Effectiveness of Fluticasone Propionate/Salmeterol (250/50mcg) Compared to Salmeterol (50mcg) in Patients with Chronic Obstructive Pulmonary Disease: Economic Evaluation of Study SCO100250
Dalal, A. A.
Blanchette, C. M.
Petersen, H.
St Charles, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[42] Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
Punekar, Yogesh Suresh
Roberts, Graeme
Ismaila, Afisi
O'Leary, Martin
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
[43] Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
Yogesh Suresh Punekar
Graeme Roberts
Afisi Ismaila
Martin O’Leary
Cost Effectiveness and Resource Allocation, 13
[44] COST-EFFECTIVENESS ANALYSIS OF INDACATEROL/GLYCOPIRRONIUM (QVA 149) AS A MAINTENANCE BRONCHODILATOR TREATMENT IN ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
Granell, M.
Giovanna, M.
Paz, S.
Betoret, I
VALUE IN HEALTH, 2014, 17 (07) : A598 - A598
[45] Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
Babu, K. Suresh
Morjaria, Jaymin B.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (02) : 56 - 68
[46] Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease.
Ghosh, Sudip
Bridge, Martin
Shahid, Nabeel
Jones, Arwell
O'Kelly, Noel
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[47] Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
Trigueros, Juan Antonio
Garin, Noe
Baloira, Adolfo
Aceituno, Susana
Calvo, Ana
Prades, Miriam
Touron, Carolina
Martinez, Anisia
Torres, Covadonga
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2905 - 2917
[48] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
Lin, John K.
Moran, Andrew E.
Tobias, Andrea P.
Kazi, Dhruv S.
CIRCULATION, 2016, 134
[49] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
Lin, John K.
Moran, Andrew E.
Tobias, Andrea P.
Kazi, Dhruv S.
CIRCULATION, 2016, 134
[50] Comparative Effectiveness Of Fluticasone Propionate/salmeterol (250/50mcg) Combination And Anticholinergics As Initial Maintenance Therapy For Chronic Obstructive Pulmonary Disease: A Retrospective Observational Cohort Study
Dalal, A. A.
Roberts, M. H.
Petersen, H. V.
Blanchette, C. M.
Mapel, D. W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183

← 1 2 3 4 5 →